Capricor Therapeutics, Inc.

NasdaqCM:CAPR Stok Raporu

Piyasa değeri: US$884.3m

Capricor Therapeutics Yönetim

Yönetim kriter kontrolleri 4/4

Capricor Therapeutics CEO'su Linda Marbán, Jan2010 tarihinde atandı, in görev süresi 14.83 yıldır. in toplam yıllık tazminatı $ 747.32K olup, şirket hissesi ve opsiyonları dahil olmak üzere 29.5% maaş ve 70.5% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.44% ine doğrudan sahiptir ve bu hisseler $ 3.88M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 12.7 yıl ve 11 yıldır.

Anahtar bilgiler

Linda Marbán

İcra Kurulu Başkanı

US$747.3k

Toplam tazminat

CEO maaş yüzdesi29.5%
CEO görev süresi14.8yrs
CEO sahipliği0.4%
Yönetim ortalama görev süresi12.7yrs
Yönetim Kurulu ortalama görev süresi11yrs

Son yönetim güncellemeleri

Here's Why Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) CEO May Have Their Pay Bumped Up

May 08
Here's Why Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) CEO May Have Their Pay Bumped Up

Recent updates

Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Sep 18
Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Investors Don't See Light At End Of Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Tunnel

Jul 30
Investors Don't See Light At End Of Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Tunnel

Here's Why Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) CEO May Have Their Pay Bumped Up

May 08
Here's Why Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) CEO May Have Their Pay Bumped Up

Benign Growth For Capricor Therapeutics, Inc. (NASDAQ:CAPR) Underpins Stock's 26% Plummet

Apr 19
Benign Growth For Capricor Therapeutics, Inc. (NASDAQ:CAPR) Underpins Stock's 26% Plummet

We're Not Very Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Rate

Apr 16
We're Not Very Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Rate

Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) 25% Dip In Price Shows Sentiment Is Matching Revenues

Feb 03
Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) 25% Dip In Price Shows Sentiment Is Matching Revenues

Is Capricor Therapeutics (NASDAQ:CAPR) In A Good Position To Invest In Growth?

Dec 13
Is Capricor Therapeutics (NASDAQ:CAPR) In A Good Position To Invest In Growth?

Here's Why We're Not Too Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Situation

Aug 13
Here's Why We're Not Too Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Situation

A Look At The Fair Value Of Capricor Therapeutics, Inc. (NASDAQ:CAPR)

Nov 03
A Look At The Fair Value Of Capricor Therapeutics, Inc. (NASDAQ:CAPR)

Capricor Therapeutics GAAP EPS of -$0.29 misses by $0.03

Aug 10

Companies Like Capricor Therapeutics (NASDAQ:CAPR) Are In A Position To Invest In Growth

Feb 01
Companies Like Capricor Therapeutics (NASDAQ:CAPR) Are In A Position To Invest In Growth

CEO Tazminat Analizi

Linda Marbán'un ücretlendirmesi Capricor Therapeutics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$28m

Mar 31 2024n/an/a

-US$24m

Dec 31 2023US$747kUS$221k

-US$22m

Sep 30 2023n/an/a

-US$29m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$29m

Dec 31 2022US$1mUS$210k

-US$29m

Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$25m

Mar 31 2022n/an/a

-US$23m

Dec 31 2021US$2mUS$200k

-US$20m

Sep 30 2021n/an/a

-US$18m

Jun 30 2021n/an/a

-US$18m

Mar 31 2021n/an/a

-US$17m

Dec 31 2020US$2mUS$150k

-US$14m

Sep 30 2020n/an/a

-US$11m

Jun 30 2020n/an/a

-US$9m

Mar 31 2020n/an/a

-US$7m

Dec 31 2019US$229kUS$157k

-US$8m

Sep 30 2019n/an/a

-US$9m

Jun 30 2019n/an/a

-US$12m

Mar 31 2019n/an/a

-US$14m

Dec 31 2018US$377kUS$233k

-US$15m

Sep 30 2018n/an/a

US$374k

Jun 30 2018n/an/a

US$2m

Mar 31 2018n/an/a

US$2m

Dec 31 2017US$602kUS$233k

US$2m

Tazminat ve Piyasa: Linda 'nin toplam tazminatı ($USD 747.32K ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 3.23M ).

Tazminat ve Kazançlar: Linda 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Linda Marbán (61 yo)

14.8yrs

Görev süresi

US$747,315

Tazminat

Dr. Linda Marbán, Ph.D. Co-founded Capricor Therapeutics, Inc. (also known as Capricor, Inc). in 2005 and also has been its Chief Executive Officer since 2010 and serves as its President. Dr. Marbán has be...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Frank Litvack
Executive Chairman of the Board12.8yrsUS$759.55k0.29%
$ 2.6m
Linda Marbán
Co-Founder14.8yrsUS$747.32k0.44%
$ 3.9m
Anthony Bergmann
CFO & Corporate Treasurer6.8yrsUS$730.85k0.0052%
$ 46.3k
Karen Krasney
Executive VP12.7yrsUS$740.77k0.044%
$ 390.0k
Kristi A. Elliott
Chief Science Officerno dataVeri yokVeri yok
Catherine Kelleher
Consultantno dataVeri yokVeri yok

12.7yrs

Ortalama Görev Süresi

64.5yo

Ortalama Yaş

Deneyimli Yönetim: CAPR 'un yönetim ekibi deneyimli ve deneyimlidir ( 12.7 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Frank Litvack
Executive Chairman of the Board12.8yrsUS$759.55k0.29%
$ 2.6m
Linda Marbán
Co-Founder11yrsUS$747.32k0.44%
$ 3.9m
George Dunbar
Independent Director11yrsUS$211.13k0.023%
$ 205.3k
Earl Collier
Independent Director11yrsUS$222.37k0.13%
$ 1.1m
David Musket
Independent Director11yrsUS$237.36k0.20%
$ 1.7m
Francesco Muntoni
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Pat Furlong
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Eugenio Mercuri
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Craig McDonald
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Oscar Mayer
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Michelle Eagle
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Michael Taylor
Member of Scientific Advisory Board6.8yrsVeri yokVeri yok

11.0yrs

Ortalama Görev Süresi

68yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CAPR 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 11 yıldır).